Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0001023024-05-000008
Filing Date
2005-05-13
Accepted
2005-05-13 17:22:49
Documents
6
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 BIOSANTE PHARMACEUTICALS 1ST QUARTER 2005 biosanteq12005.htm 10QSB 607679
2 EXHIBIT 10.2 exhibit10w2.htm EX-10.2 15319
3 SECTION 302 CERTIFICATION CEO exhibit31w1.htm EX-31.1 11526
4 SECTION 302 CERTIFICATION CFO exhibit31w2.htm EX-31.2 11322
5 SECTION 906 CERTIFICATION CEO exhibit32w1.htm EX-32.1 4226
6 SECTION 906 CERTIFICATION CFO exhibit32w2.htm EX-32.2 4226
  Complete submission text file 0001023024-05-000008.txt   655871
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 001-31812 | Film No.: 05830597
SIC: 2836 Biological Products, (No Diagnostic Substances)